Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pei-Hsin Cheng

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector prepsMark A Brimble, Pei-Hsin Cheng, Stephen M Winston, et al.
Molecular Therapy. Advances|May 15, 2026
Rational engineering of the P5 TRS-mimic site and REP78/68 start codon yields promoter variants that improve rAAV purity while maintaining high titersStephen M Winston, Mark A Brimble, Kristin B Wiggins, et al.
Iscience|November 3, 2018
KDM5A Regulates a Translational Program that Controls p53 Protein ExpressionDongli Hu, Carolyn Jablonowski, Pei-Hsin Cheng, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector prepsMark A Brimble, Pei-Hsin Cheng, Stephen M Winston, et al.
Molecular Therapy. Advances|May 15, 2026
Rational engineering of the P5 TRS-mimic site and REP78/68 start codon yields promoter variants that improve rAAV purity while maintaining high titersStephen M Winston, Mark A Brimble, Kristin B Wiggins, et al.
Iscience|November 3, 2018
KDM5A Regulates a Translational Program that Controls p53 Protein ExpressionDongli Hu, Carolyn Jablonowski, Pei-Hsin Cheng, et al.
Pageof 2